Tablet fluvoxamine (100 mg/day) combined with placebo as control group for 8 weeks

2 trials

Sponsors

Tehran University of Medical Sciences

Conditions

Obsessive- Cumpulsive Disorder. Obsessive-compulsive disorder

Phase 3

ondansetron in the treatment of obsessive-compulsive disorder

Active, not recruitingIRCT201204271556N41

Tehran University of Medical SciencesObsessive- Cumpulsive Disorder. Obsessive-compulsive disorder

Start: 2012-04-29Target: 40Updated: 2018-02-22

Riluzole in the treatment of obsessive compulsive disorder

Active, not recruitingIRCT201211211556N48

Tehran University of Medical SciencesObsessive- Cumpulsive Disorder. Obsessive-compulsive disorder

Start: 2012-03-20Target: 50Updated: 2018-02-22